Ultra Clean Holdings, Inc. (UCTT): what the price assumes

In the published model solve dated 2026-Q2, anchored at $80.26, Ultra Clean Holdings, Inc. (UCTT) is priced for today's economics sustained for ~15.9 years. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-06-28.

Generated: 2026-08-10 · Exported: 2026-08-12 · Source: https://boothcheck.com/report/UCTT

Headline

FieldValue
TickerUCTT
CompanyUltra Clean Holdings, Inc.
Current price$80.26/sh
CompositionProducts 88% / Services 12%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin (value-band context)5.2%
Operating margin (mid-cycle)5.1%
Margin expansion (value-band)+0.1pp
Trailing margin (depressed year)-5.3%
Must persist for15.9y
Multiple paid39x mid-cycle operating income

The operating-margin figure is value-band context at year 10: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

Solve inputs: computed at a 13% cost of capital; growth searched up to the 25% self-funding ceiling; each 1pp moves the implied horizon ~2.5 years.

Reconcile: at the x-ray's 9.3% required return this reads ~7.9 years; the models below use their own rates.

How unusual the bet is: elevated

ReferenceValue
vs own history-0.21σ
sustained it ~10 years at this level15%
implied end-window share0%

Valuation X-Ray

Every valuation family lands below the price. The price therefore sits beyond what those standard frames encode.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset6.11x2expensive
Earnings8.70x1expensive
Relative0
Growth2.09x1expensive

Families that call it expensive: Asset, Earnings, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 7.8%); the inversion above states its own rate.

Per-Model Detail (n=4)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$0.00noReference only (OCF-based, capex excluded): OCF $0.0B
DCF Exit MultipleGrowth$0.00noNegative/zero FCF or EBITDA — equity value floored at $0
Relative ValuationRelativenoP/S fallback (negative EPS): Sector P/S 5.0x × TTM revenue — excluded from consensus
Simple DDMGrowthno
Two-Stage DDMGrowthno
Simple Excess ReturnAsset$13.865.79xyesReference only (book value floor): BV/sh $13.86, ROE negative
Two-Stage Excess ReturnAsset$12.476.44xyesReference only (book value with convergence): BV/sh $13.86, ROE converges to ke
Discounted Future Market CapGrowth$38.462.09xyesRev $2.1B, growth -3% (input: historical growth; tapered), Terminal P/S: 1.5x / 1.8x / 2.0x (bear / base = today's held flat / bull, cap 8x)
Peter Lynch Fair ValueRelative$0.00noNegative/zero EPS — earnings-based value floored at $0
Margin TrajectoryGrowthno
Earnings Power ValueEarnings$9.238.70xyesNormalized EBIT (5y avg op income, one-time charges added back) $0.09B × (1−21%) / WACC 7.7% → EPV (no growth)
Residual IncomeAssetno
Graham NumberAssetno
EV/EBITDA RelativeRelativenoEBITDA $0.06B × sector EV/EBITDA 16.0x
FCF YieldEarningsno
SBC-Adj FCF YieldEarningsno
Ben Graham FormulaEarningsno
ROIC-Justified P/BAsset$1.4953.87xyesBV $13.86 × (ROIC 0.8% / WACC 7.7%) (excluded from median)
P/Sales SectorRelativenoRevenue $2.07B × sector P/S 5.0x
PEG Fair ValueRelativeno
Earnings YieldEarningsno
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Economic-Unit Decomposition (Sum Of The Parts)

One or more material disclosed units has unresolved economics. Unknown/general is not evidence of homogeneity: segment SOTP is primary but incomplete, consolidated cash flow may remain only a secondary cross-check when every unit shares an enterprise basis, and one sector multiple or target margin is withheld.

UnitRoleValuation basisRevenueReported profitValue evidenceStatus
Productsoperatingenterprise$1.8bwithheldunresolved no unit value
Servicesoperatingenterprise$254.7mwithheldunresolved no unit value

No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.

Solvency

FieldValue
Net debt$288.3m
Net debt / NOPAT (after-tax)3.48x
Net debt / operating income (pre-tax)2.75x
Interest coverage2.9x
Share count CAGR (buyback)-0.2%
Burning cashno

Leverage and coverage are computed on normalized mid-cycle operating income (mid-cycle margin 5.1%); the trailing year was depressed.

Bullet Takeaways

Bull Case

The number that decides everything for Ultra Clean is gross margin, and it is finally moving the right way. Q1 2026 gross margin reached 16.5%, up 40 basis points sequentially, split between product margin of 14.6% and a much richer services margin of 30%. In a business this operationally leveraged, a few points of margin is the difference between a GAAP loss and real profit, and the sequential expansion is the early signal that the cycle is turning up. The company posted revenue of $533.7 million and non-GAAP EPS of $0.31, beating estimates, then guided Q2 revenue higher to $565 million to $605 million with non-GAAP EPS of $0.44 to $0.60. That guidance step-up is margin and volume compounding together.

The position in the supply chain is the structural reason the upside can be large. Ultra Clean designs and assembles the subsystems inside wafer-fab equipment, and the 10-K describes a Customer Business Management organization of engineers who provide "sub-system design through to design for manufacturability" recommendations and develop "long-term, multi-level relationships" with customers. That is co-engineering, not commodity supply. Being embedded in a customer's tool design at the engineering level creates switching costs that a pure contract manufacturer lacks, and it is why the company can capture a services margin near double its product margin.

The demand backdrop is a genuine multi-year tailwind. Customers are projecting $140 billion to $145 billion in wafer-fab-equipment spend for 2026, an 18% to 20% increase, and management frames the AI-driven capital-equipment expansion as still in its early stages. Ultra Clean has put a number on the opportunity, targeting $4 billion in revenue by 2030 in its spring investor update. The filing also flags continued "strategic acquisitions" to broaden the model and diversify into adjacent markets. If WFE spending compounds as customers expect, a thin-margin subsystem supplier with engineering lock-in is exactly the kind of operating-leverage story that earns its way into profit.

Bear Case

Strip away the AI narrative and the plain fact is that Ultra Clean does not currently earn a profit on a GAAP basis, while its price assumes years of strong, sustained profitability it has not demonstrated. That is the disconnect. The company runs a slightly negative operating margin today, and the price embeds a path to mid-single-digit-or-better operating margins sustained for a very long horizon. For a supplier whose gross margin sits at 16.5%, reaching and holding a healthy operating margin requires both the cyclical upturn to persist and the company to hold the line on cost in a business where it has limited pricing power. The market is paying for an outcome the trailing numbers have not produced.

The pricing-power problem is structural and the filing states it plainly. Ultra Clean's largest customers, "due to their size and level of contribution to our revenue", are able to "exert significant pressure to seek various concessions in our commercial agreements and individual purchase orders". A subsystem supplier concentrated among a few enormous equipment makers is a price-taker by design. When the cycle is strong the customers tolerate the supplier's margin; when it softens, they push concessions through, and the supplier's thin margin is the first thing to compress. The 16.5% gross margin is not a fortress; it is a number the customers help set.

Cyclicality turns the operating leverage from a feature into a hazard. The same leverage that lifts margin in an upturn slices it in a downturn, and wafer-fab-equipment spending is one of the most cyclical lines in technology. The implied bet in the price requires the current upcycle to extend across a horizon far longer than any single semiconductor cycle has historically lasted. Net debt of about $288 million against negative operating income leaves interest coverage around three times today, adequate while the cycle cooperates but a real constraint if WFE spend rolls over before the margin recovery is complete. The price is underwriting a long, smooth expansion in an industry that does not historically deliver one.

Valuation

Ultra Clean is priced as a recovery and growth bet, and the methods we use to triangulate make the stretch visible. Because the company currently runs a GAAP loss, the methods anchored on trailing profitability either cannot find a meaningful base or land far below the price, and the only lens that supports the current level is the peer-multiple approach, which values the company on revenue and sector multiples rather than current earnings. When the sole supportive method is the one that looks past profitability, the price is a forward bet, not a value case.

What the price requires, stated concretely, is a forward operating margin near the high single digits sustained over a very long horizon, against a slightly negative margin today. That is a full cyclical recovery plus durable margin expansion, and the duration the inversion implies is unusually long precisely because the starting point is a loss. The bet only pays if the AI-driven WFE upcycle is as multi-year and as smooth as customers project, and if Ultra Clean converts higher volume into the operating margin its thin gross margin has so far not delivered. The methods that respect current economics are emphatic that this is expensive on what the business earns now.

Solvency is the constraint that bounds the bet, and it belongs at the close. Net debt of about $288 million sits against negative trailing operating income, with liquid assets of roughly $323 million and interest coverage near three times providing a cushion that holds while the cycle is up. The balance sheet is not in distress, but it has less room than the price assumes if the upcycle pauses. The decisive question is timing: whether the margin recovery completes before the next downturn arrives, because a thin-margin, cyclical supplier priced for a long expansion has little tolerance for the cycle turning early.

Catalysts

Q1 2026 was a beat-and-raise that supports the upcycle thesis. Revenue came in at $533.7 million with a GAAP net loss of $17.9 million but non-GAAP EPS of $0.31, ahead of consensus, while gross margin expanded 40 basis points sequentially to 16.5%. Product revenue rose to $465.7 million and services to $68 million, the higher-margin services line growing alongside products.

Guidance pointed higher. For Q2 2026, management expects revenue of $565 million to $605 million, GAAP diluted EPS of $0.20 to $0.36, and non-GAAP diluted EPS of $0.44 to $0.60, a meaningful sequential step that, if delivered, would move the company solidly into GAAP profit. The non-GAAP figures are the company's own convention; the GAAP quarter was still a loss.

The catalysts ahead are the industry's, not just the company's. Customers projecting $140 billion to $145 billion of wafer-fab-equipment spend in 2026, an 18% to 20% rise, set the demand backdrop, and management's framing of an early-stage, multi-year AI-driven expansion is the bull premise. The $4 billion 2030 revenue target is the long-range marker. Each quarter's gross-margin print is the cleanest read on whether the operating leverage is converting the volume into profit fast enough to earn the price.

Peer Cohorts (Per Segment, With Filing Citations)

Products / Services (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

UCTT Q1 2026 earnings call, 2026 · UCTT Q1 2026 results, 2026 · UCTT Q1 2026 guidance, 2026 · UCTT Spring 2026 investor update, 2026 · UCTT Q2 2026 guidance, 2026

View the full interactive UCTT report on boothcheck